Is transcutaneous auricular vagus nerve stimulation effective and safe for primary insomnia? A PRISMA-compliant protocol for a systematic review and meta-analysis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0313101 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, 2024. Verfasst von Ting Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou City, China. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Systematic Reviews as Topic, Meta-Analysis as Topic, Vagus Nerve Stimulation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Province Public Welfare Technology Application Research, Zhejiang Provincial Famous Traditional Chinese Medicine Experts Inheritance Studio Construction Project.
Themen: Schlaf
Abstract (Originalsprache)
Background
Insomnia is a highly prevalent sleep disorder with substantial impacts on health and quality of life. Current treatment options have certain limitations, highlighting the need for novel therapeutic approaches. Transcutaneous auricular vagus nerve stimulation (ta-VNS) is gaining recognition as a promising non-invasive neuromodulation technique for treating insomnia, but its efficacy has not been systematically evaluated. Therefore, this protocol outlines the framework for a systematic review and meta-analysis designed to comprehensively assess the effectiveness and safety of ta-VNS in treating primary insomnia.
Methods
A thorough literature search will be carried out in Embase, PubMed, the Cochrane Library, PsycINFO, AMED, PEDro, Wangfang database, Chinese National Knowledge Infrastructure, and Chinese BioMedical Literature Database, covering publications from their inception until December 31, 2024. Randomized controlled trials evaluating ta-VNS for primary insomnia in adults will be included. Two independent reviewers will screen studies, gather data, and evaluate the risk of bias based on the Cochrane RoB 2.0 tool. Meta-analyses will be conducted where appropriate, and the quality of evidence will be evaluated using GRADE. Subgroup and sensitivity analyses are planned.
Discussion
This systematic review and meta-analysis will deliver a thorough synthesis of existing evidence regarding the efficacy and safety of ta-VNS for insomnia, potentially informing clinical practice and future research directions.
Trial registration
PROSPERO registration number: CRD42024529039 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Nursing, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou City, China.
- Department of Rehabilitation, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou City, China.
- Department of Acupuncture and Moxibustion, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou City, China.
ORCID-Profile: Hantong Hu
Förderung
- Zhejiang Province Public Welfare Technology Application Research
- Zhejiang Provincial Famous Traditional Chinese Medicine Experts Inheritance Studio Construction Project
Zitieren
APA
Yang, T., Cai, Y., Li, X., Fang, L., & Hu, H. (2024). Is transcutaneous auricular vagus nerve stimulation effective and safe for primary insomnia? A PRISMA-compliant protocol for a systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0313101
Vancouver
Yang T, Cai Y, Li X, Fang L, Hu H. Is transcutaneous auricular vagus nerve stimulation effective and safe for primary insomnia? A PRISMA-compliant protocol for a systematic review and meta-analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0313101
BibTeX
@article{Yang2024,
author = {Yang, Ting and Cai, Yunhuo and Li, Xingling and Fang, Lianqiang and Hu, Hantong},
title = {Is transcutaneous auricular vagus nerve stimulation effective and safe for primary insomnia? A PRISMA-compliant protocol for a systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0313101}
}
EUVIMED